Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption

Detalhes bibliográficos
Autor(a) principal: Almeida, Victor Miranda de
Data de Publicação: 2024
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/164634
Resumo: Dissertation presented as the partial requirement for obtaining a Master's degree in Data Driven Marketing, specialization in Data Science for Marketing
id RCAP_47da76b953e8ea3c6417c1d153ac5d76
oai_identifier_str oai:run.unl.pt:10362/164634
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoptionDigital TransformationPharmaceutical IndustryDigitalizationValue CreationSDG 3 - Good health and well-beingSDG 4 - Educação de qualidadeSDG 8 - Decent work and economic growthSDG 9 - Industry, innovation and infrastructureSDG 10 - Reduced inequalitiesSDG 11 - Sustainable cities and communitiesSDG 17 - Partnerships for the goalsDomínio/Área Científica::Ciências Naturais::Ciências da Computação e da InformaçãoDissertation presented as the partial requirement for obtaining a Master's degree in Data Driven Marketing, specialization in Data Science for MarketingThe digital transformation phenomenon is already a reality for most of the sectors and organizations of different sizes. The transformation powered by the adoption and use of disruptive technologies such as 5G network, Cloud Technology (CT), Internet of Things (IoT), Artificial Intelligence (AI) & Machine Learning (ML), Advanced Robotics, augmented (AR) and Virtual Reality (VR) and Big Data (BD) led to changes in the organization processes, ways of working, product, and service conception. The disruptive technologies, when correctly employed have the potential to improve productivity, reduce costs, create new offerings, mitigate, and reduce risk, creating and unlocking value to companies. It is a consensus among scholars and practitioners that the COVID 19 outbreak totally changed and accelerated the need for the adoption of digital technologies, not simply by surfing the trend, but for the survival of the organizations. The Pharmaceutical and Healthcare industries are among the companies that lately have been employing disruptive technologies to become more efficient and innovative, looking to improve internal processes, reducing cost, driving innovation, mitigating risks, developing of new offerings of products and services. Using a Design Science Research and survey with experienced professionals, it was found that the most relevant factors to the adoption of disruptive technology within pharmaceutical and healthcare are “Leadership sponsorship”, “Clear digital transformation long term vision/strategy”, “Willingness to experiment”. Considering the adoption and use of disruptive technologies drives significant changes in the organizations, the objective of this thesis is to seek understanding on the factors and its relevance to organization under the digital transformation process, with the intention to shed light on the enablers that should be taken into account by practitioners in this situation. The work developed in this dissertation and the findings could help practitioners to better understand which factors should be considered during a digital transformation process. For scholars, this dissertation promotes a discussion of areas urging for more research and studies in order to better understand the digital transformation within the pharmaceutical and healthcare sectors and the impacts on value creation for firms and patients.Rodrigues, Jorge Manuel CarrolaRUNAlmeida, Victor Miranda de2024-01-312027-01-31T00:00:00Z2024-01-31T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/164634TID:203543670enginfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:53:35Zoai:run.unl.pt:10362/164634Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:00:17.854749Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
title Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
spellingShingle Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
Almeida, Victor Miranda de
Digital Transformation
Pharmaceutical Industry
Digitalization
Value Creation
SDG 3 - Good health and well-being
SDG 4 - Educação de qualidade
SDG 8 - Decent work and economic growth
SDG 9 - Industry, innovation and infrastructure
SDG 10 - Reduced inequalities
SDG 11 - Sustainable cities and communities
SDG 17 - Partnerships for the goals
Domínio/Área Científica::Ciências Naturais::Ciências da Computação e da Informação
title_short Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
title_full Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
title_fullStr Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
title_full_unstemmed Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
title_sort Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
author Almeida, Victor Miranda de
author_facet Almeida, Victor Miranda de
author_role author
dc.contributor.none.fl_str_mv Rodrigues, Jorge Manuel Carrola
RUN
dc.contributor.author.fl_str_mv Almeida, Victor Miranda de
dc.subject.por.fl_str_mv Digital Transformation
Pharmaceutical Industry
Digitalization
Value Creation
SDG 3 - Good health and well-being
SDG 4 - Educação de qualidade
SDG 8 - Decent work and economic growth
SDG 9 - Industry, innovation and infrastructure
SDG 10 - Reduced inequalities
SDG 11 - Sustainable cities and communities
SDG 17 - Partnerships for the goals
Domínio/Área Científica::Ciências Naturais::Ciências da Computação e da Informação
topic Digital Transformation
Pharmaceutical Industry
Digitalization
Value Creation
SDG 3 - Good health and well-being
SDG 4 - Educação de qualidade
SDG 8 - Decent work and economic growth
SDG 9 - Industry, innovation and infrastructure
SDG 10 - Reduced inequalities
SDG 11 - Sustainable cities and communities
SDG 17 - Partnerships for the goals
Domínio/Área Científica::Ciências Naturais::Ciências da Computação e da Informação
description Dissertation presented as the partial requirement for obtaining a Master's degree in Data Driven Marketing, specialization in Data Science for Marketing
publishDate 2024
dc.date.none.fl_str_mv 2024-01-31
2024-01-31T00:00:00Z
2027-01-31T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/164634
TID:203543670
url http://hdl.handle.net/10362/164634
identifier_str_mv TID:203543670
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138178540503040

Registros relacionados